Preface content

  • Pirbright’s new bird flu vaccine provides rapid protection, could reduce

    virus spread and is less costly to produce

  • Pirbright’s award winning COVID-19 response

  • Why vaccines matter in the fight against zoonotic diseases

  • Key mutations in Alpha variant enable SARS-CoV-2 to overcome

    evolutionary weak points

  • Pirbright midges featured in ZSL London Zoo exhibit

  • New Animal Vaccine Manufacturing and Innovation Centre

    to be established at Pirbright

  • Visit our Coronavirus Hub

  • Current vacancies at Pirbright

  • Director's vision

Innovation and collaboration

Trim content

® The Pirbright Institute 2021 | A company limited by guarantee, registered in England no. 559784. The Institute is also a registered charity.